Robert Florentine resumes & CV records
Resumes
Robert Florentine
Location:
United States
Robert E Florentine, 704 Randolph Blvd, Marmora, NJ 08223
Robert Florentine Phones & Addresses
4 Randolph Blvd, Marmora, NJ 08223
Woodbine, NJ
257 St Clair Ct, Mount Laurel, NJ 08054
Manlius, NY
Norristown, PA
Marlton, NJ
Malvern, PA
Syracuse, NY
Social networks
Robert E Florentine
Linkedin
Mentions for Robert E Florentine
Publications & IP owners
Us Patents
Treatment Of Glaucoma And Other Retinopathies With Gangliosides
US Patent:
2012022, Aug 30, 2012
Filed:
Feb 28, 2012
Appl. No.:
13/407072
Inventors:
Jay S. Schneider - Cherry Hill NJ, US
Gerri Henwood - Malvern PA, US
Robert Florentine - Naples FL, US
David W. Anderson - West Chester PA, US
Gerri Henwood - Malvern PA, US
Robert Florentine - Naples FL, US
David W. Anderson - West Chester PA, US
International Classification:
A61K 31/7028
A61P 9/10
A61P 27/02
C07H 15/10
A61P 27/06
A61P 9/10
A61P 27/02
C07H 15/10
A61P 27/06
US Classification:
514 25, 536 179
Abstract:
A method of treating or preventing a retinopathy such as glaucoma in a human patient in need thereof comprising administering one or more gangliosides to the patient.
Ganglioside Transmucosal Formulations
US Patent:
2012022, Aug 30, 2012
Filed:
Feb 28, 2012
Appl. No.:
13/407296
Inventors:
Jay S. Schneider - Cherry Hill NJ, US
John J. Koleng - Austin TX, US
Robert Florentine - Naples FL, US
David W. Anderson - West Chester PA, US
John J. Koleng - Austin TX, US
Robert Florentine - Naples FL, US
David W. Anderson - West Chester PA, US
International Classification:
A61K 31/7028
A61M 31/00
A61M 11/00
A61P 25/00
A61P 25/16
A61M 31/00
A61M 11/00
A61P 25/00
A61P 25/16
US Classification:
514 25, 12820014, 604286
Abstract:
A transmucosal formulation comprising a ganglioside and a mucosal absorption enhancer, as well as a method of treating or preventing Parkinson's disease in a human patient in need thereof comprising parenterally administering such a transmucosal formulation to said patient.
Methods For Extraction And Purification Of Gangliosides
US Patent:
2012022, Aug 30, 2012
Filed:
Feb 28, 2012
Appl. No.:
13/407067
Inventors:
Jay S. Schneider - Cherry Hill NJ, US
Gerri Henwood - Malvern PA, US
Robert Florentine - Naples FL, US
Christopher Barber - Audobon PA, US
Gerri Henwood - Malvern PA, US
Robert Florentine - Naples FL, US
Christopher Barber - Audobon PA, US
International Classification:
C08B 37/00
C12P 19/02
C12P 19/02
US Classification:
536 53, 435105
Abstract:
Methods for purification and extraction of GM1 ganglioside from cells derived from sheep afflicted with GM1 gangliosidosis or from cells derived from human patients with GM1 gangliosidosis as stable and renewable sources of GM1.
Apparatus For Weaving A Three-Dimensional Article
US Patent:
4312261, Jan 26, 1982
Filed:
May 27, 1980
Appl. No.:
6/153623
Inventors:
Robert A. Florentine - Norristown PA
International Classification:
D04C 100
US Classification:
87 33
Abstract:
An apparatus for weaving a three-dimensional article from a plurality of weaving elements comprising a plurality of carrier members each including a separate weaving element supply mounted thereon. The separate weaving elements are fed from the weaving element supplies to a plane of fabrication. Supporting means is provided for releasably maintaining the carrier members in a matrix to form a carrier plane. Movement means is provided to move the carrier members in predetermined paths relative to each other within the matrix to intertwine the weaving elements to form the woven article. A takeup means is provided to draw the woven article away from the carrier plane.
Treatment Of Glaucoma And Other Retinopathies With Gangliosides
US Patent:
2014030, Oct 16, 2014
Filed:
Apr 17, 2014
Appl. No.:
14/255554
Inventors:
- Malvern PA, US
Gerri Henwood - Malvern PA, US
Robert Florentine - Naples FL, US
David W. Anderson - West Chester PA, US
Gerri Henwood - Malvern PA, US
Robert Florentine - Naples FL, US
David W. Anderson - West Chester PA, US
Assignee:
LZ Therapeutics, Inc. - Malvern PA
International Classification:
A61K 31/7028
A61K 45/06
A61K 45/06
US Classification:
514 25, 536 179
Abstract:
A method of treating or preventing a retinopathy such as glaucoma in a human patient in need thereof comprising administering one or more gangliosides to the patient.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.